Features
Fresofungin (Anidulafungin) is an intravenous echinocandin antifungal agent. It is semi-synthetic lipopeptide synthesized from a fermentation product of Aspergillus nidulans. Anidulafungin was approved for the treatment of candidemia and other Candida infections (intra-abdominal, peritonitis) and esophageal candidiasis in February 2006.